Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-12-12
1991-12-03
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546133, A61K 31435, C07D22102
Patent
active
050700952
ABSTRACT:
Novel 1-(azabicyclo[2.2.2]oct-3- or -4-yl)benzamides substituted on the benzene ring with the basic substituted aminomethyleneamino group have been found to be useful in treating emesis, including emesis due to chemical and radiation anticancer therapy, anxiety, and impaired gastric emptying. These compounds are represented by Formula I below. ##STR1##
REFERENCES:
patent: 4593034 (1986-06-01), Munson et al.
patent: 4657911 (1987-04-01), Imbert et al.
Chem. Abs. 100, 174466e (Abstract of Spanish Patent ES 516729A1).
J. Med. Chem. 31, 1548-1558 (1988), Monkovic et al.
Jagdmann, Jr. Gunnar E.
Munson, Jr. Harry R.
A. H. Robins Company Incorporated
Raymond Richard L.
Tarnowski George
LandOfFree
Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1697189